Boston, MA -- (SBWIRE) -- 11/01/2013 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: diaDexus, Inc. (OTCMKTS:DDXS), Zynga Inc (NASDAQ:ZNGA), MannKind Corporation (NASDAQ:MNKD), AcelRx Pharmaceuticals Inc (NASDAQ:ACRX).
diaDexus, Inc. (OTCMKTS:DDXS), opened its shares at the price of $2.10for the day. Its closing price was $2.00 after losing -4.76% for the day. The company traded with the total volume of 394,663 shares, while its average trading volume remained 290,630 shares. The beta of DDXS stands at1.06.
Will DDXS Get Buyers Even After The Recent Rally? Find Out Here
diaDexus, Inc., a life sciences company, focuses on the development and commercialization of proprietary cardiovascular diagnostic products addressing needs in cardiovascular disease.
Zynga Inc (NASDAQ:ZNGA), percentage change plunged -0.25% to close at $3.58 with the total traded volume of 19.33 million shares, and average volume of 28.33 million. The 52 week range of the stock remained $2.09 - $4.05, while its day lowest price was $3.84and it hit its day highest price at $3.59.
Will ZNGA Get Buyers Even After The Recent Rally? Find Out Here
Zynga Inc. develops, markets, and operates online social games as live services on the Internet, social networking sites, and mobile platforms in the United States and internationally.
MannKind Corporation (NASDAQ:MNKD), started its trading session with the price of $4.97 and closed at $4.91 by scoring –0.30%. MNKD’s stocks traded with total volume of 5.94 million shares, while the average trading volume remained 4.97million shares. The beta of MNKD stands at 1.63. Day range of the stock was $4.77 -$5.11.
Will MNKD Get Buyers Even After The Recent Rally? Find Out Here
MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer in the United States.
AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) ended its day with the gain of 1.05% and closed at the price of $6.72 after opening at $6.64. Stock traded during its last trading session with the total volume of 1.93 million shares, as compared to its average volume of 774,918 shares.
Will ACRX Continue To Move Higher? Find Out Here
AcelRx Pharmaceuticals, Inc., a development stage specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute and breakthrough pain.
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/ and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)